News
-
Dispensary Corner 09 Sep 25
Tuesday | Sep 9 2025WE'VE all heard of insurance fraud, but some people take things way too far for a payout.
-
PATY awarded to Jessica Brown of Vic
Monday | Sep 8 2025JESSICA Brown, from Emerald Village Pharmacy in Melbourne, has been named the Pharmacy Guild of Australia/Maxigesic 2025 Pharmacy Assistant of the Year (PATY).
-
Communication is key, says PDL
Monday | Sep 8 2025HELPFUL resources are available to help pharmacists assist patients who may have difficulty understanding health-related information, including a free translation and interpretation service and multilingual health information.
-
GSK prize to accelerate AI diagnostics
Monday | Sep 8 2025WORLD-LEADING virologist from the University of Sydney, Professor Edward Holmes, has been awarded the 2025 GSK Award for Research Excellence for his pioneering use of metatranscriptomics and artificial intelligence (AI) to identify viruses, improve diagnostics, and better understand how infectious disease epidemics emerge.
-
Retinoid action
Monday | Sep 8 2025DIFFERIN Acne Treatment contains the potent retinoid Adapalene to treat and prevent acne, and restore the skin's natural texture and tone.
-
Healthy workplace
Monday | Sep 8 2025THE Pharmacy Guild of Australia is hosting a webinar, 'Creating a mentally healthy pharmacy workplace', for pharmacy owners and managers - see the cover page for details.
-
Swisse appoints
Monday | Sep 8 2025H&H GROUP has announced the appointment of Yolanda Uys as Director of Growth & Brand for Australia and New Zealand for Swisse.
-
All treat, no tricks
Monday | Sep 8 2025CUSTOMERS have a chance to win the ultimate Halloween treat haul - a year's supply of Glucojel products.
-
T2D prevention hotline launches
Monday | Sep 8 2025DIABETES Australia has launched 1800PREVENT (type 2 diabetes), a free national hotline and website that will support individuals at risk of type 2 diabetes (T2D) to navigate health resources.
-
PBAC consults on obesity drugs
Monday | Sep 8 2025THE Department of Health and Ageing has advised that public consultation is now open around the listing of glucagon-like peptide-1 receptor agonist (GLP-1) medicines such as Ozempic and Mounjaro for the treatment of obesity.
